Zurich Cantonal Bank’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,449
| Closed | -$118K | – | 2660 |
|
|
2024
Q4 | $118K | Buy |
7,449
+2,078
| +39% | +$32.9K | ﹤0.01% | 2377 |
|
|
2024
Q3 | $312K | Buy |
5,371
+1,994
| +59% | +$116K | ﹤0.01% | 1854 |
|
|
2024
Q2 | $154K | Sell |
3,377
-1
| -0% | -$46 | ﹤0.01% | 2168 |
|
|
2024
Q1 | $224K | Buy |
3,378
+301
| +10% | +$19.9K | ﹤0.01% | 1996 |
|
|
2023
Q4 | $122K | Sell |
3,077
-37
| -1% | -$1.47K | ﹤0.01% | 2350 |
|
|
2023
Q3 | $99.3K | Sell |
3,114
-106
| -3% | -$3.38K | ﹤0.01% | 2354 |
|
|
2023
Q2 | $129K | Buy |
3,220
+2,691
| +509% | +$108K | ﹤0.01% | 2205 |
|
|
2023
Q1 | $22.6K | Buy |
529
+118
| +29% | +$5.04K | ﹤0.01% | 2731 |
|
|
2022
Q4 | $19.7K | Sell |
411
-79
| -16% | -$3.79K | ﹤0.01% | 2757 |
|
|
2022
Q3 | $18K | Hold |
490
| – | – | ﹤0.01% | 2815 |
|
|
2022
Q2 | $14K | Sell |
490
-40
| -8% | -$1.14K | ﹤0.01% | 2830 |
|
|
2022
Q1 | $29K | Sell |
530
-254
| -32% | -$13.9K | ﹤0.01% | 2615 |
|
|
2021
Q4 | $46K | Sell |
784
-42
| -5% | -$2.46K | ﹤0.01% | 2768 |
|
|
2021
Q3 | $33K | Sell |
826
-11
| -1% | -$439 | ﹤0.01% | 2722 |
|
|
2021
Q2 | $36K | Buy |
837
+27
| +3% | +$1.16K | ﹤0.01% | 2517 |
|
|
2021
Q1 | $50K | Buy |
+810
| New | +$50K | ﹤0.01% | 2387 |
|